Washington D.C. - The U.S. government has canceled a $766 million contract with Moderna, a pharmaceutical company, that was designed to bolster pandemic preparedness. The contract, awarded previously, was intended to fund research and development of vaccines and therapeutics for potential future pandemics, including threats such as avian influenza (bird flu).
The decision to terminate the agreement raises questions about the nation's strategy for responding to emerging infectious diseases. Moderna was expected to utilize the funds to accelerate its research efforts and expand its manufacturing capacity for rapid vaccine production.
Government officials have not yet provided a detailed explanation for the cancellation. Further details are expected to be released in the coming days. Experts are now assessing the potential impact on the nation's ability to quickly respond to future public health crises.
US Cancels Moderna Pandemic Preparedness Contract
The U.S. government has terminated a $766 million contract with Moderna, a pharmaceutical company, aimed at preparing for future pandemics. This contract was intended to support the development of vaccines and treatments for potential threats, including bird flu. The cancellation raises concerns about the nation's preparedness for emerging infectious diseases. Officials have not yet released a detailed explanation for the decision.
Source: Read the original article at NBC